H1N1 in Households, or the Math of Spreading Swine Flu

H1N1 Swine Flu Awareness : Click to view full-size image by miamism (Ines Hegedus-Garcia)

How quickly will health authorities detect the next pandemic? How will we measure the effectiveness of preventative anti-virus medications? A new report from researchers at the University of Warwick provides the math for a statistical method to help estimate the answers to these questions.

A Math Study on How Quickly Swine Flu may Spread in Households

Estimation of outbreak severity and transmissibility…” explains how a research team tracked the transmission of the H1N1 swine flu in Birmingham, England during the first seven weeks of the 2009 pandemic.

One key question concerned “transmissibility”: how readily did this H1N1 strain infect a healthy person who lived in the same household with someone already suffering from an active case of influenza?


After patients with symptoms were confirmed by laboratory tests as infected with the H1N1 flu, their housemates were “swabbed” for further tests. Once the pandemic was well established, however, doctors began to treat everyone as having H1N1 flu, without waiting for lab results, which limited the statistical survey period.

The survey included 424 initial cases from 424 different households, and then an additional 1612 participants from those households.

Ready to swab for a swine flu test: image by irina slutsky

At the outset of an H1N1 epidemic, doctors generally require patients who have symptoms to undergo laboratory tests to confirm that the cause truly is swine flu, rather than seasonal influenza. Leaping to the “swine flu” conclusion without tests could lead to reporting inflated infection rates and using excessive doses of prescription medication. In Birmingham, the H1N1 influenza was mild enough that the researchers believed many cases went unreported; so an H1N1 pandemic might not be recognized in time to protect the vulnerable.

Click to Read Page Two: Statistical Study of 2009 Swine Flu

Pages: 1 2 3

  • Gord5467

    I was with the Canadian Forces in 2009, was ordered to get the H1N1 shot (AREPANRIX by GSK GlaxoSmithKline) and had an adverse reaction to the vaccine. I received PERMANENT neurological, cardiovascular, gastrointestinal, and respiratory symptoms: dizziness, vertigo, irregular heart rhythms, shortness of breath, muscle weakness and pain, and numbness in hands and feet. My physical fitness changed from special forces fit to that of a 70 year old in a matter of days. Prior to the vaccination the Department of National Defence (DND) provided information advising side effects “having mild chills and fever a few days following the shot means it is working”, and “There is a 1 in 1,000,000 chance of acquiring a serious neurological complication”. According to GSKs product information provided by Health Canada, “neurological disorders” are “very rare (may occur with up to 1 in 10,000 doses)” and “if any of these side effects occur, please tell your doctor or nurse immediately” which differs from the information provided to soldiers. The DND also stated “It is not a live vaccine so it cannot give you the flu”. According to Dr. Danuta Skowronski, an epidemiologist and an influenza expert at the B.C. Centre for Disease Control, “In the early weeks of the pandemic that people who got the flu shot (H1N1) for 2008-09 winter seemed to be more likely to get infected with the pandemic virus than people who hadn’t received the shot”. Another study linked narcolepsy, a neurological disorders to the H1N1 vaccine, “Narcolepsy in association with pandemic influenza vaccination”, September 2012, European Centre for Disease Prevention and Control. You may also query the National Vaccine Information Center database of adverse reactions to vaccines (VAERS) which includes more than 11,465 events (adverse reactions) to the H1N1 vaccine, 3,390 symptoms and 61,500 reactions (more than 5 reactions per record). In the UK, the “FINAL PUBLIC SUMMARY – UK Suspected Adverse Reaction Analysis, Swine Flu (H1N1) Vaccines – Celevanpan and Pandemrix, 26 March 2010″ details more than 8,600 suspected reactions classified into 650 reaction names. Other information to consider is from Richard Warrington, President of the Canadian Society of Allergy and Clinical Immunology, “Vaccination with Arepanrix has led to far more reports of anaphylaxis or significant allergic reactions than is normally expected for a flu vaccine.” You may also ask your doctor and other Health care workers if they received the H1N1 vaccination and if they plan to remain up to date with all vaccinations. Reports from Canada, US, India, Hong Kong and other countries note a 50% vaccination rate among those who recommend and administer the immunization. According to Fox News “Most said they would pass on the H1N1 shot … because they were afraid of side effects and doubted how safe and effective it would be.” I asked my doctor and he didn’t hesitate in saying “no way”. Be informed and please choose wisely if you do plan to have your next flu shot or vaccination.